| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000004155 |
| Receipt No. | R000004989 |
| Official scientific title of the study | Evaluation of optimal dose of local anesthetics for patient controlled coutinuous femoral nerve block with sciatic nerve block after total knee arthroplasty |
| Date of disclosure of the study information | 2010/09/03 |
| Last modified on | 2016/10/30 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Evaluation of optimal dose of local anesthetics for patient controlled coutinuous femoral nerve block with sciatic nerve block after total knee arthroplasty | |
| Title of the study (Brief title) | Evaluation of optimal dose of local anesthetics for patient controlled continuous femoral nerve block | |
| Region |
|
|
| Condition | |||
| Condition | Patients required total knee arthroplasty | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Evaluation of analgesic effect without basal administration of local anesthestics for patient-controlled femoral nerve block (with sciatic nerve block) after total knee arthroplasty |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Analgesic effect after total knee arthroplasty, Dose of local anesthetics, Additional analgesics (time of administration, drugs), Adverse efffect of nerve blocks, Progress of rehabilitation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Dose comparison |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patient-controlled femoral nerve block with basal administration of 0.2% ropivacaine.
Basal dose: 3 ml/h, Bolus dose 5 ml, Lock out time: 60 minutes, Duration of administration: 4 days after the operation |
|
| Interventions/Control_2 | Patient-controlled femoral nerve block without basal administration of 0.2% ropivacaine.
Basal dose: 0 ml/h, Bolus dose 8 ml, Lock out time: 60 minutes, Duration of administration: 4 days after the operation |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients scheduled total knee arthroplasty more than 20 years old | |||
| Key exclusion criteria | none | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Hideki Taninishi |
| Organization | Okayama University Hospital |
| Division name | Department of Anesthesiology and Resuscitology |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama city, Japan |
| TEL | |
| Public contact | |
| Name of contact person | Hideki Taninishi |
| Organization | Okayama University Hospital |
| Division name | Department of Anesthesiology and Resuscitology |
| Address | |
| TEL | |
| Homepage URL | |
| tanishi@ops.dti.ne.jp | |
| Sponsor | |
| Institute | Okayama University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004989 |